🇺🇸 SRPT — Sarepta Therapeutics, Inc.
Salud MantenerPrecio actual
17,82 USD
Máx. histórico
178,74
2145 días
Split 1:6 del 12/07/2012
Caída desde máximo
-90,03%
Rango 52 semanas
14,68 – 24,68
Variación hoy
+1,42%
Cierre anterior
17,57
Rango de hoy
17,52 – 18,77
Volumen hoy
2.596.193
Peor caída histórica
-98,17%
09/02/2000 → 18/12/2008
Recuperado en 3568 días
Volatilidad anualizada ⓘ
95,43%
- Nombre completo
- Sarepta Therapeutics, Inc.
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 835
- PER ⓘ
- —
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 21,64 USD (puede no estar actualizado)
- Primera cotización
- 04/06/1997
- Precio actualizado
- hace 12 horas
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.
| Fecha | Ratio |
|---|---|
| 12/07/2012 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 25/01/2017 | 30,74 | 31,39 | 29,88 | 30,25 | -1,59% | 4,91% | 1.546.100 |
| 24/01/2017 | 31,34 | 31,89 | 30,56 | 30,74 | -2,13% | 4,24% | 2.054.000 |
| 23/01/2017 | 32,55 | 32,63 | 31,22 | 31,41 | -3,83% | 4,33% | 1.612.200 |
| 20/01/2017 | 34,29 | 34,67 | 32,44 | 32,66 | -4,59% | 6,50% | 2.168.400 |
| 19/01/2017 | 36,04 | 36,23 | 34,02 | 34,23 | -4,86% | 6,13% | 2.190.800 |
| 18/01/2017 | 36,27 | 36,92 | 35,79 | 35,98 | -0,42% | 3,12% | 1.710.500 |
| 17/01/2017 | 37,50 | 37,50 | 36,03 | 36,13 | -4,49% | 3,92% | 2.202.500 |
| 13/01/2017 | 36,57 | 38,55 | 36,57 | 37,83 | +2,99% | 5,41% | 2.649.600 |
| 12/01/2017 | 35,92 | 37,35 | 35,00 | 36,73 | +3,32% | 6,54% | 3.189.600 |
| 11/01/2017 | 38,24 | 38,27 | 35,04 | 35,55 | -6,18% | 8,45% | 5.516.000 |
| 10/01/2017 | 31,44 | 39,36 | 27,84 | 37,89 | +21,21% | 36,64% | 14.830.400 |
| 09/01/2017 | 30,42 | 31,56 | 29,74 | 31,26 | +3,92% | 5,98% | 2.718.700 |
| 06/01/2017 | 29,77 | 31,16 | 29,25 | 30,08 | +1,90% | 6,42% | 3.239.900 |
| 05/01/2017 | 29,26 | 29,76 | 28,39 | 29,52 | +0,96% | 4,68% | 2.328.700 |
| 04/01/2017 | 27,59 | 29,89 | 27,52 | 29,24 | +4,73% | 8,59% | 2.988.800 |
| 03/01/2017 | 28,35 | 28,42 | 27,20 | 27,92 | +1,79% | 4,30% | 2.175.600 |
| 30/12/2016 | 27,56 | 27,79 | 26,66 | 27,43 | -0,72% | 4,10% | 1.565.900 |
| 29/12/2016 | 28,30 | 28,50 | 27,14 | 27,63 | -2,61% | 4,81% | 1.652.200 |
| 28/12/2016 | 29,01 | 29,27 | 28,16 | 28,37 | -1,90% | 3,83% | 1.311.200 |
| 27/12/2016 | 30,00 | 30,18 | 28,65 | 28,92 | -3,28% | 5,10% | 1.530.100 |
| 23/12/2016 | 28,51 | 29,98 | 28,51 | 29,90 | +6,18% | 5,16% | 2.190.800 |
| 22/12/2016 | 30,72 | 31,20 | 28,08 | 28,16 | -4,51% | 10,16% | 3.099.000 |
| 21/12/2016 | 29,37 | 29,92 | 28,62 | 29,49 | -0,51% | 4,43% | 2.088.200 |
| 20/12/2016 | 30,01 | 30,08 | 29,13 | 29,64 | -1,17% | 3,17% | 1.727.500 |
| 19/12/2016 | 30,97 | 31,47 | 29,69 | 29,99 | -3,63% | 5,75% | 1.474.600 |
| 16/12/2016 | 30,47 | 31,56 | 30,01 | 31,12 | +1,93% | 5,09% | 3.009.900 |
| 15/12/2016 | 29,96 | 31,08 | 29,36 | 30,53 | +1,83% | 5,74% | 2.175.200 |
| 14/12/2016 | 30,85 | 31,20 | 29,22 | 29,98 | -5,78% | 6,42% | 3.474.100 |
| 13/12/2016 | 31,59 | 32,33 | 31,28 | 31,82 | +0,51% | 3,32% | 1.192.200 |
| 12/12/2016 | 32,48 | 32,64 | 31,04 | 31,66 | -3,06% | 4,93% | 1.837.900 |